Infection Control Market

The report "Infection Control Market by Product (Sterilization (Hydrogen Peroxide, EtO, Gamma, E-Beam), Disinfection (Wipes, Liquids, Disinfectors), Services, Gowns, Endoscope Reprocessing), End User (Hospital & Clinics, Pharmaceuticals) - Global Forecast to 2029", is valued at an estimated USD 51.0 billion in 2024 and is projected to reach USD 69.2 billion by 2029, at a CAGR of 6.3% during the forecast period.

Browse 635 market data Tables and 59 Figures spread through 640 Pages and in-depth TOC on "Infection Control Market by Product (Sterilization (Hydrogen Peroxide, EtO, Gamma, E-Beam), Disinfection (Wipes, Liquids, Disinfectors), Services, Gowns, Endoscope Reprocessing), End User (Hospital & Clinics, Pharmaceuticals) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html

The infection control market has grown as a result of many drivers, including rising healthcare-associated infections (HAIs) and antibiotic resistance drive demand for innovative solutions. Aging populations with weakened immune systems, coupled with an increase in complex surgeries and minimally invasive procedures, create fertile ground for infection risks.

Technological advancements like automation, artificial intelligence in disinfection robots, and nanotechnology-based antimicrobial surfaces offer promising solutions. Sustainability is gaining traction, with eco-friendly disinfectants and reusable personal protective equipment (PPE) gaining favor. Furthermore, growing awareness of occupational hazards in healthcare settings fuels demand for safer equipment and training. This dynamic market is poised for continued growth, driven by the relentless pursuit of preventing infections and safeguarding public health.

The market growth of infection control is significantly boosted by advancements in sterilization equipment technology. These innovations enhance efficiency and efficacy in sterilization processes, meeting rising demands for infection prevention across various industries. As technology evolves, businesses can access more sophisticated solutions, driving market expansion and improving overall infection control standards.

Furthermore, the infection control industry is growing as the number of surgical operations increases. With surgical interventions becoming more common, there's a heightened need for stringent infection prevention measures. This surge in surgical activities drives the demand for infection control products and services. As healthcare facilities strive to maintain sterile environments, the market expands to meet the increasing requirements, fostering business opportunities within the industry.

The Infection Control Market is further segmented based on product & service, end user and region.

The cleaning and disinfection product segment holds the largest market share during the forecast period.

Cleaning and disinfection products hold the largest market share in the infection control market. This dominance stems from their pivotal role in preventing the spread of infections across various sectors. As businesses and healthcare facilities prioritize cleanliness and hygiene, the demand for effective cleaning and disinfection solutions continues to surge. These products play a crucial role in maintaining sanitized environments, especially in the face of heightened awareness about infectious diseases. With stringent regulations and standards driving the need for robust infection control measures, cleaning and disinfection products remain indispensable, commanding a significant portion of the market.

The Endoscope reprocessing product segment is expected to grow at the highest rate during the forecast period.

Endoscope reprocessing products have recorded the highest Compound Annual Growth Rate (CAGR) in the infection control market. This remarkable growth can be attributed to the increasing utilization of endoscopic procedures in medical diagnostics and treatments. As endoscopes are extensively used across healthcare facilities, the demand for effective reprocessing solutions escalates to ensure the safety and reliability of these devices. With a growing emphasis on infection prevention and patient safety, healthcare providers are investing more in advanced endoscope reprocessing products to meet stringent regulatory requirements and mitigate the risk of Healthcare-Associated Infections (HAIs). Consequently, manufacturers in the infection control market are focusing on innovating and enhancing their endoscope reprocessing product lines.

The remarkable rise underscores the critical role these products play in ensuring patient safety and infection prevention. With the increasing adoption of endoscopic procedures in medical diagnosis and treatment, there's a parallel surge in demand for reliable and efficient reprocessing solutions. Manufacturers are responding to this growing demand by continually innovating and improving their endoscope reprocessing product offerings, thereby driving further market growth.

In the end-user segment, hospitals and clinics hold the largest market share in the Infection Control Market.

In 2023, the hospitals & clinics segment dominated the infection control market. The infection control market for hospitals and clinics is booming, fueled by several key factors and trends. Firstly, the rising prevalence of hospital-acquired infections (HAIs) and antibiotic-resistant bacteria creates a constant need for stricter hygiene protocols and advanced technology. Secondly, an aging population with weakened immune systems increases susceptibility to infections, demanding more robust prevention measures. Additionally, the growing number of surgical procedures and minimally invasive surgeries necessitates meticulous sterilization practices.
Furthermore, public awareness of pandemics like COVID-19 has heightened focus on sanitation and personal protective equipment (PPE), driving demand for these products. Technological advancements play a crucial role, with innovations like ultraviolet disinfection systems, automated hand hygiene dispensers, and robotic cleaners gaining traction. Looking ahead, the market is expected to see increased adoption of single-use medical devices, outsourcing of sterilization services, and a focus on sustainable infection control solutions. Overall, the convergence of these factors positions the infection control market for hospitals and clinics for continued significant growth in the coming years.

North America will continue to dominate the Infection Control Market in 2029.

On the basis of region, the Infection Control Market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa and GCC countries. Firstly, North America's robust healthcare infrastructure and advanced medical facilities drive significant demand for infection control products and services. Additionally, stringent regulatory standards and heightened awareness of healthcare-associated infections (HAIs) propel the adoption of infection prevention measures. Moreover, the region's strong emphasis on research and development fosters innovation in infection control technologies, further solidifying North America's position as a leader in the global infection control market.

Key Players

The global Infection Control Market is consolidated in nature, with the top players, namely, STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Advanced Sterilization Products (US), Sotera Health LLC (US), MMM Group (Germany), MATACHANA GROUP (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), Olympus Corporation (Japan). Melag Medizintechnik GmbH & Co. KG (Germany), Miele Group (Germany), Systec GmbH & Co. KG(Germany), Contec, Inc. (US), Continental Equipment Company (US), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US) accounting for a larger share of the market.

Don’t miss out on business opportunities in Infection Control Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]